491 related articles for article (PubMed ID: 28240774)
21. Advances in biomarker research for pancreatic cancer.
Bhat K; Wang F; Ma Q; Li Q; Mallik S; Hsieh TC; Wu E
Curr Pharm Des; 2012; 18(17):2439-51. PubMed ID: 22372502
[TBL] [Abstract][Full Text] [Related]
22. Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer.
Guo J; Xie K; Zheng S
Int J Biol Sci; 2016; 12(3):292-301. PubMed ID: 26929736
[TBL] [Abstract][Full Text] [Related]
23. Label-free characterization of exosome via surface enhanced Raman spectroscopy for the early detection of pancreatic cancer.
Carmicheal J; Hayashi C; Huang X; Liu L; Lu Y; Krasnoslobodtsev A; Lushnikov A; Kshirsagar PG; Patel A; Jain M; Lyubchenko YL; Lu Y; Batra SK; Kaur S
Nanomedicine; 2019 Feb; 16():88-96. PubMed ID: 30550805
[TBL] [Abstract][Full Text] [Related]
24. Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.
Zhang X; Shi S; Zhang B; Ni Q; Yu X; Xu J
Am J Cancer Res; 2018; 8(3):332-353. PubMed ID: 29636993
[TBL] [Abstract][Full Text] [Related]
25. Molecular Imaging with MRI: Potential Application in Pancreatic Cancer.
Chen C; Wu CQ; Chen TW; Tang MY; Zhang XM
Biomed Res Int; 2015; 2015():624074. PubMed ID: 26579537
[TBL] [Abstract][Full Text] [Related]
26. Screening for Pancreatic Cancer.
Ngamruengphong S; Canto MI
Surg Clin North Am; 2016 Dec; 96(6):1223-1233. PubMed ID: 27865274
[TBL] [Abstract][Full Text] [Related]
27. Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature.
Ghatnekar O; Andersson R; Svensson M; Persson U; Ringdahl U; Zeilon P; Borrebaeck CA
Int J Cancer; 2013 Nov; 133(10):2392-7. PubMed ID: 23649606
[TBL] [Abstract][Full Text] [Related]
28. Genomics in Primary and Secondary Prevention of Pancreatic Cancer.
Malats N; Molina-Montes E; La Vecchia C
Public Health Genomics; 2017; 20(2):92-99. PubMed ID: 28689205
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
Urayama S
World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
[TBL] [Abstract][Full Text] [Related]
30. The role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers.
Jin H; Wu Y; Tan X
Clin Transl Oncol; 2017 Aug; 19(8):921-930. PubMed ID: 28168600
[TBL] [Abstract][Full Text] [Related]
31. Prediagnostic Image Data, Artificial Intelligence, and Pancreatic Cancer: A Tell-Tale Sign to Early Detection.
Young MR; Abrams N; Ghosh S; Rinaudo JAS; Marquez G; Srivastava S
Pancreas; 2020 Aug; 49(7):882-886. PubMed ID: 32675784
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?
O'Neill RS; Stoita A
World J Gastroenterol; 2021 Jul; 27(26):4045-4087. PubMed ID: 34326612
[TBL] [Abstract][Full Text] [Related]
33. DNA Fingerprint Technology: Its Application in Detecting Pancreatic Cancer.
Chalikonda G; Merchant N; Lakkakula BVKS; Nagaraju GP
Crit Rev Oncog; 2019; 24(2):133-137. PubMed ID: 31679208
[TBL] [Abstract][Full Text] [Related]
34. Early detection markers in Pancreas Cancer.
Farrell JJ; van Rijnsoever M; Elsaleh H
Cancer Biomark; 2005; 1(2-3):157-75. PubMed ID: 17192037
[TBL] [Abstract][Full Text] [Related]
35. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
Alix-Panabières C; Pantel K
Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic cancer and cancer screening programs: from nihilism to hope.
Pezzilli R; Corinaldesi R; Morselli-Labate AM
JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511
[No Abstract] [Full Text] [Related]
37. Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent Surgery.
Søreide K; Ismail W; Roalsø M; Ghotbi J; Zaharia C
Cancer Control; 2023; 30():10732748231154711. PubMed ID: 36916724
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers for pancreatic cancer: recent achievements in proteomics and genomics through classical and multivariate statistical methods.
Marengo E; Robotti E
World J Gastroenterol; 2014 Oct; 20(37):13325-42. PubMed ID: 25309068
[TBL] [Abstract][Full Text] [Related]
39. A Panel of Three Biomarkers Identified by iTRAQ for the Early Diagnosis of Pancreatic Cancer.
Wu X; Zhang ZX; Chen XY; Xu YL; Yin N; Yang J; Zhu DM; Li DC; Zhou J
Proteomics Clin Appl; 2019 Sep; 13(5):e1800195. PubMed ID: 31025496
[TBL] [Abstract][Full Text] [Related]
40. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
